Curevac strengthens leadership team with appointment of seasoned industry executive axel sven malkomes as chief financial officer

Experienced cfo and investment banker with 30-year track record will help drive curevac's transformation tÜbingen, germany and boston, ma / accesswire / november 4, 2024 / curevac n.v. (nasdaq:cvac) ("curevac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), today announced the appointment of axel sven malkomes as chief financial officer, effective november 11, 2024.
CVAC Ratings Summary
CVAC Quant Ranking